Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet licensed by the MHRA or EMA, with Phase 2 data showing substantial weight reduction over 48 weeks
With its proven ability to deliver superior results and minimal injection frequency, it has become a preferred treatment option for individuals seeking medically supervised, long-term weight management and improved overall well-being
Matsunaga, S
Taste and Solubility Amanda gave the 1st Phorm Endura-Formance a 4.5 out of 5 for taste and a 4 out of 5 for solubility
Almeida, Oclio R
US$ 21.40
US$ 22.82
US$ 25.80
US$ 22.07
US$ 23.92
US$ 24.64
US$ 28.82
US$ 22.10
